Michael M. Allevato

University of California, San Diego — United States

Economics, Econometrics and Finance · Social Sciences

10h-index763citations96works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Innovation Policy and R&D(17), Cancer Immunotherapy and Biomarkers(14), PI3K/AKT/mTOR signaling in cancer(13), Advanced Breast Cancer Therapies(12), Semiconductor materials and devices(11)

Publications96 total

Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
2026Open Access
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
SSRN Electronic Journal·2026Open Access
676 Lymphatic-sparing immunoradiotherapy reprograms migratory dendritic cells to drive tumor rejection via the sentinel lymph node
Regular and Young Investigator Award Abstracts·2025Open Access
Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy
Advanced Science·2025· 1 citedOpen Access
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
Nature Communications·2025· 10 citedOpen Access
Abstract 3764: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Cancer Research·2025
Costs of Sleep Endoscopy With Same‐Day Versus Staged Surgery for Pediatric Obstructive Sleep Apnea
OTO Open·2025Open Access
Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 3 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Tables 2 -5 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Table 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Abstract B019: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Cancer Immunology Research·2025
Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Clinical Cancer Research·2025
Supplementary Figure 2 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
2024Open Access
Data from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
2024Open Access
Supplementary Figure 3 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
2024Open Access
Supplementary Figure 1 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
2024Open Access
Supplementary Figure 5 from Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism
2024Open Access
page 1 of 5Next →

Frequent Co-authors

J. Silvio Gutkind(40), Yusuke Goto(24), Zhiyong Wang(20), Keiichi Koshizuka(20), Xingyu Wu(19), Hiroki Izumi(19), Xiaodong Feng(18), Prashant Mali(18), Kuniaki Sato(18), Alfredo Molinolo(17), Toshinori Ando(17), Kyle Ford(17), Nadia Arang(17), Ayush Kishore(17), Tomohiko Ishikawa(16), Zhiyong Wang(16), Joseph A. Califano(15), Mara Gilardi(13), Victoria H. Wu(10), Lynn Vitale‐Cross(10)